pear-vc - Head of Life Sciences - Manta Cares

• Life Science fluency (12+ years): in commercial or medical affairs, or at a vendor that sells into pharma (RWD, diagnostics / biopharma, eClinical, CRO, point-of-care). You know how pharma buys across medical affairs, brand, and market access, and you understand procurement, MLR, and the budget cycle. • Live buyer relationships: active, warm relationships with decision-makers at the VP / Sr-Director level that translate into meetings now. Real and current, not five years stale. • A personal closing track record: you have personally closed consultative six-to-seven-figure deals (co-developed partnerships, data / services, or platform deals, not transactional SaaS). You can walk one specific deal end to end: the buyer, the value story, the structure, the cycle, and the close. • Quota DNA: you have personally carried and hit a bookings quota. A doer who sources, pitches, and closes. • Startup-stage adaptability: You can operate without a built-out commercial org, marketing engine, or sales-ops, and build the motion as you go. You have worked with young, seed-stage startups. • Location: East Coast based, or willing to travel extensively. • You have sold a data or engagement asset (RWD licensing, patient engagement / point-of-care, or diagnostics-biopharma). • Deep oncology and precision-medicine relationships specifically, versus broad healthcare. • You have stood up a commercial function from scratch (0-to-1). • Channel or partnership dealmaking experience. • A personal or mission connection to cancer and patients. • THIS ROLE IS NOT FOR YOU IF • You know everyone but have never personally signed a six-to-seven-figure deal. • You run teams that sell but have not carried a bag in years. • Your experience is corp-dev or licensing only. You have bought or licensed assets for a pharma, but never sold services or data into pharma. • Your selling is transactional SaaS: quick-cycle, self-serve, no long consultative cycles. • You need a built-out machine (marketing, SDRs, sales-ops, a roadmap) handed to you. • You treat a patient base as an ad audience rather than the trust asset that makes Manta different.